University of California, San Diego
San Diego, California, 92093, United States
NCT Number: NCT02006394
Clinical and rodent studies have demonstrated the impact of specific dietary factors in modulating inflammation-related diseases including insulin resistance, type 2 diabetes, and cardiovascular disease. Such dietary factors include polyunsaturated fats, polyphenols, and glycemic index. The investigators know from previous studies in the literature that reducing the glycemic index and increasing the omega-3 fat and polyphenol content of the diet results in improved metabolic indices and reduced inflammation. These improvements can be observed even within the context of persistent obesity. The investigators will implement a reduced-calorie, multi-pronged dietary approach for improving insulin sensitivity and reducing inflammation in obese subjects with the metabolic syndrome. The active diet will include reduced glycemic index foods together with omega-3 fats and polyphenol supplements. The primary hypothesis is that the dietary combination of reduced glycemic index foods, omega-3 fats and polyphenols will work to reduce insulin resistance and inflammation more efficiently than a placebo-controlled, calorie- and macronutrient-matched diet in obese subjects with the metabolic syndrome.
Looking for future studies?
Notify Me21 year–55 year
All sexes
Interventional
Not applicable
San Diego, California, 92093, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
fish oil capsules
delphinidin polyphenol capsules
Corn Oil Capsules
Maltodextrin capsules
Made by Zone Labs
placebo bread products
Time frame: Baseline, 6 weeks, and 12 weeks
Fasting plasma insulin, Homeostasis Model of Assessment - Insulin Resistance (HOMA-IR)
Time frame: Baseline, 6 weeks, 12 weeks
Fasting plasma cytokines and C-reactive protein (CRP), monocyte expression of inflammatory genes
Time frame: Baseline, 6 weeks, 12 weeks
Fasting plasma adiponectin and leptin
University of California, San Diego
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07241741
Body Weight, C-reactive Protein
View Trial DetailsNCT02663544
Body Weight, Diabetes
Seattle, Washington, United States
View Trial DetailsNCT06697977
Body Weight, Diabetes
Amman, Jordan
View Trial DetailsNCT03344718
Atrophy, Avitaminosis
Tainan, Taiwan
View Trial Details